Check out our new paper in @MolNeuro where we dive deeper into how amyloid-targeting antibodies impact cerebrovascular health, revealing key immune responses and potential ways to protect the brain💥🧠. https://t.co/fMPIBppsbv
Resilience against AD neuropathology might rely on the amyloid plaque microenvironment. Want to learn more? Check out our paper in Acta Neuropathologica! Excellent job @NurJury@pbmartinc@EChimalJ in the lab and our collabs @jungsukim77@HandeKarahan_ https://t.co/ZhLSvfh95A
Non-classical monocytes patrol the vascular tree and are nurtured by peripheral via adhesion provided CSF1
@ImmunityCP @BajenoffL
https://t.co/h4w5jRGtsM
Researchers at AD/PD 2024 presented new mouse models of CAA and ARIA, and proposed potential biomarkers of the former and treatments for the latter. #alzheimersdisease@Radboud_Uni@UABBarcelona@adpdnet https://t.co/7aKcmOJ2Ij
This year's #RainwaterPrize Innovative Early-Career Scientist winner Dr. Cristian Lasagna Reeves is passionate about furthering tau research to better understand neurodegenerative disorders. Learn about Dr. @LasagnaLabwork’s work & his lab
@IUMedSchool: https://t.co/sc07NPUgvf
Congratulations to Cristian A. Lasagna Reeves, PhD, for receiving the @RCFNeuro#RainwaterPrize for Innovative Early-Career Scientist: https://t.co/M8pUh1qwKi
The second autopsy report from a person who died with ARIA while on Leqembi shows severe vascular pathology similar to CAA-ri. #alzheimersdisease@VanderbiltU https://t.co/2qMUdz8PC5
📢🚨Thrilled to announce my first first-author paper with @EliLillyandCo was published this morning in @MolNeuro!
Thank you to all the lab members, collaborators, and everyone who made this possible! 🧠🔬
https://t.co/ROxIvcFpGf
Very excited to share that my first first-author paper with @jungsukim77 was published this morning in @JExpMed 😄
Thank you to all the lab members, collaborators, and everyone who made this possible!